Is HALO stock a Buy, Sell, or Hold?

Based on our analysis, HALO is currently a HOLD with moderate confidence. 📊 HOLD: HALO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of HALO stock?

Our analysis estimates the fair value range for HALO to be between $67.86 and $70.77. The current price is $71.15.

What is the analyst price target for HALO?

The average Wall Street analyst price target for HALO is $83.90. This implies a potential upside of 17.9% from current levels.

HALO Stock Analysis: Buy, Sell, or Hold?

HALO - Halozyme Therapeutics, Inc.

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

$71.15

1.53 (2.20%) ▲

5d: +2.17%

30d: +4.14%

90d: +14.68%

HOLD

MODERATE Confidence

Protect Your HALO Gains

Analysis Updated: Jun 24, 2026 12:00 AM ET

Earnings: Aug 04, 2026

Smart Money Accumulation

None View Scanner →

Strength: 4.4/10

Get Alerted When HALO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: HALO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 21.5%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$135.97

Based on 12.8% avg growth

INTRINSIC VALUE TODAY

$84.42

15.7% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.6x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: HALO is currently trading at $71.15, which is considered extended relative to its 30-day fair value range of $67.86 to $70.77. The stock's valuation (Forward PE: 7.2) is in line with its historical norms (7.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This pessimistic expectation contrasts with the company's recent 31.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, HALO is in a strong uptrend. The price is approaching resistance at $72.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $83.90 (+17.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $67.86 - $70.77

Company Quality Score 60/100 (BUY)

Volume Confirmation HIGH

Confidence Score 48.6%

Protect Your Profits

Holding HALO? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
NEUTRAL: Mixed technical signals (55/100)
BULLISH: High volume confirmation
BULLISH: Trading below Wall St target ($83.90)

Trading Range Analysis

30-Day Trading Range $67.86 - $70.77

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $67.02

Resistance Level $72.25

Current Trend Strong Uptrend

Technical data as of Jun 24, 2026

Fundamental Context

Forward P/E (Next Year Est.) 7.19

Wall Street Target $83.90 (+17.9%)

Revenue Growth (YoY) 42.2%

Earnings Growth (YoY) 31.2%

Profit Margin 23.1%

Valuation Discount vs History -1.7% cheaper

PE vs Historical 7.2 vs 7.6 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -1.7% (market-implied from PE analysis)

1-Year Target $69.94 (-2%)

2-Year Target $68.75 (-3%)

3-Year Target $67.58 (-5%)

3-Yr Target (if PE normalizes) (PE: 7→8) $71.41 (+0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 21.8, Growth: 21.5%) $386.61 (+443%)

Base: (SPY PE: 7.2, Growth: 21.5%) $127.66 (+79%)

Bear: (PE: 6.1, Growth: 21.5%) $108.51 (+53%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (7x PE) as earnings recover.

Trailing PE: 24.43 | Current EPS (TTM): $2.85

Bull Case $153.16 (+115%)

Analyst growth 100.0%, PE expands to 26.9

Base Case $139.24 (+96%)

Market implied 100.0%, PE stable at 24.4

Bear Case $47.34 (-34%)

Severe decline -20.0%, PE contracts to 20.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 7.2 to 7.6

Stabilization Target: $75.18 (+5.7%)

PE Expansion Potential: +5.7%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: June 25, 2026 4:31 AM ET
Data refreshes hourly during market hours. Next update: 5:31 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is HALO showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Helen Torley SELL 10000 shares 2026-04-06

Helen Torley SELL 20000 shares 2026-04-02

Cortney Caudill SELL 8857 shares 2026-03-10

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for HALO.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NTLA Intellia Therapeutics Inc	STRONG BUY 29 analysts	$27	57 HOLD
ONC BeiGene, Ltd.	STRONG BUY 24 analysts	$412	58 HOLD
ARGX argenx NV ADR	STRONG BUY 22 analysts	$1022	56 HOLD
ACLX Arcellx Inc	STRONG BUY 18 analysts	$113	57 HOLD
MRUS Merus BV	STRONG BUY 17 analysts	$97	55 HOLD

NTLA Intellia Therapeu…

Advanced HALO Option Strategies

Professional options setups generated by AI based on today's HALO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for HALO

HALO Technical Chart HALO Price Prediction HALO Earnings Date HALO Investment Advisor HALO Fair Price Analyzer HALO Options Advisor HALO Options Chain HALO Options Analysis HALO Competitors

Compare HALO with Peers

HALO vs PTCT
Which one to buy?

HALO vs NBIX
Which one to buy?

HALO vs AGIO
Which one to buy?

HALO vs ALNY
Which one to buy?

HALO vs CYTK
Which one to buy?

HALO vs CAI

HALO vs PTCT

ABVX vs HALO

BCRX vs HALO
Winner: HALO

PMCB vs HALO

HALO vs RVMD

HALO vs MDGL

HALO vs CORT
Winner: HALO

HALO vs JAZZ

DNLI vs HALO

Create New Comparison View All Competitors

Tradestie